Table 1.
Demographic, clinical and laboratory data of the patients
| Variable | MS according to NCEP-ATP III criteria | MS according to IDF criteria | ||||
| With MS (n = 364) | Without MS (n = 136) | p value | With MS (n = 419) | Without MS (n = 81) | p value | |
| Age (years)* | 65.9 ± 10.0 | 62.0 ± 12.9 | 0.002 | 65.6 ± 10.2 | 61.6 ± 13.6 | 0.010 |
| Diabetes duration (years) | 12.7 ± 8.4 | 11.5 ± 8.5 | 0.166 | 12.5 ± 8.3 | 11.7 ± 8.9 | 0.389 |
| BMI (kg/m2) | 30.0 ± 5.2 | 26.7 ± 4.3 | <0.001 | 29.9 ± 5.0 | 25.9 ± 4.8 | <0.001 |
| Waist (cm) males | 108 ± 11 | 98 ± 9 | <0.001 | 107 ± 10 | 95 ± 11 | <0.001 |
| Waist (cm) females | 105 ± 9 | 89 ± 17 | <0.001 | 104 ± 10 | 89 ± 20 | <0.001 |
| Serum HDL (mg/d) males | 42 ± 10 | 51 ± 11 | <0.001 | 44 ± 11 | 51 ± 12 | <0.001 |
| Serum HDL (mg/dl) females | 49 ± 10 | 61 ± 10 | <0.001 | 50 ± 11 | 61 ± 10 | <0.001 |
| Serum triglycerides (mg/dl) | 172 ± 91 | 106 ± 50 | <0.001 | 164 ± 90 | 111 ± 57 | <0.001 |
| SBP (mmHg) | 134 ± 19 | 126 ± 14 | <0.001 | 134 ± 19 | 123 ± 11 | <0.001 |
| DBP (mmHg) | 79 ± 11 | 75 ± 8 | <0.001 | 79 ± 11 | 74 ± 6 | <0.001 |
| Glycosylated hemoglobin (%) | 7.1 ± 1.3 | 7.0 ± 1.3 | 0.137 | 7.1 ± 1.3 | 7.0 ± 1.3 | 0.416 |